As an additional example, in lymphoma, activity of the NFkB pathway, which is constitutively deregulated in lymphoma development19, correlates with resistance when using antimetabolites, a common type of chemotherapy (Fig. 3, Supplementary Fig. S3k). The gene discussed is NFKB1; the disease is lymphoma.